Renaissance Technologies
IMDX

Renaissance Technologies’s Insight Molecular Diagnostics IMDX Stock Holding History

Renaissance Technologies’s Portfolio IMDX Stock Details IMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,400
Closed -$101K – 3557
2025
Q4 		$101K Sell
13,400
-10,200
-43% -$57.6K ﹤0.01% 3013
2025
Q3 		$78.4K Sell
23,600
-2,500
-10% -$7.05K ﹤0.01% 3288
2025
Q2 		$78.8K Buy
+26,100
New +$78.9K ﹤0.01% 3335
2024
Q3 		– Sell
-10,418
Closed -$30.7K – 3779
2024
Q2 		$30.7K Sell
10,418
-1,800
-15% -$4.95K ﹤0.01% 3339
2024
Q1 		$36K Sell
12,218
-500
-4% -$1.54K ﹤0.01% 3531
2023
Q4 		$32K Buy
12,718
+500
+4% +$1.54K ﹤0.01% 3522
2023
Q3 		$38K Buy
12,218
+5,313
+77% +$19.8K ﹤0.01% 3441
2023
Q2 		$32K Buy
6,905
+3,925
+132% +$19.8K ﹤0.01% 3693
2023
Q1 		$21K Buy
2,980
+1,570
+111% +$11.7K ﹤0.01% 3815
2022
Q4 		$9K Buy
+1,410
New +$15.5K ﹤0.01% 4040
2022
Q2 		– Sell
-7,873
Closed -$235K – 4466
2022
Q1 		$235K Sell
7,873
-522
-6% -$16.7K ﹤0.01% 3581
2021
Q4 		$364K Buy
8,395
+5,550
+195% +$319K ﹤0.01% 3249
2021
Q3 		$203K Sell
2,845
-935
-25% -$86K ﹤0.01% 3202
2021
Q2 		$434K Sell
3,780
-1,735
-31% -$169K ﹤0.01% 3014
2021
Q1 		$572K Buy
+5,515
New +$524K ﹤0.01% 2860
2020
Q3 		– Sell
-3,735
Closed -$143K – 3589
2020
Q2 		$143K Buy
+3,735
New +$193K ﹤0.01% 3219
2019
Q2 		– Sell
-6,810
Closed -$538K – 3705
2019
Q1 		$538K Buy
+6,810
New +$439K ﹤0.01% 2900

Other funds holding IMDX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Renaissance Technologies's IMDX Position: Q1 2026 in Review

Renaissance Technologies sold out of Insight Molecular Diagnostics (IMDX) in Q1 2026, closing a stake of 13,400 shares — an estimated $101K sold.

Renaissance Technologies first reported a position in IMDX in Q1 2019 and held it in 17 quarters. The position peaked at $572K in Q1 2021. 41 funds tracked by Wall St. Rank hold IMDX as of Q1 2026.

  • Renaissance Technologies reported no remaining Insight Molecular Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Renaissance Technologies sold 13,400 Insight Molecular Diagnostics shares in Q1 2026, an estimated $101K.
  • Renaissance Technologies first reported a position in Insight Molecular Diagnostics in Q1 2019 and held it in 17 quarters.
  • Renaissance Technologies's Insight Molecular Diagnostics position peaked at $572K in Q1 2021.
  • 41 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.